Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02520154
Title Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

ovarian cancer

Therapies

Carboplatin + Paclitaxel

Pembrolizumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
MD Anderson in Katy Houston Texas 77094 United States Details
MD Anderson League City Nassau Bay Texas 77058 United States Details
MD Anderson in Sugar Land Sugar Land Texas 77478 United States Details
MD Anderson in The Woodlands The Woodlands Texas 77384 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field